179 related articles for article (PubMed ID: 1860056)
1. Corticotropin releasing factor antagonist reduces ischemic hippocampal neuronal injury.
Lyons MK; Anderson RE; Meyer FB
Brain Res; 1991 Apr; 545(1-2):339-42. PubMed ID: 1860056
[TBL] [Abstract][Full Text] [Related]
2. Differential antagonist activity of alpha-helical corticotropin-releasing factor9-41 in three bioassay systems.
Fisher L; Rivier C; Rivier J; Brown M
Endocrinology; 1991 Sep; 129(3):1312-6. PubMed ID: 1651845
[TBL] [Abstract][Full Text] [Related]
3. Effects of noise on high-affinity choline uptake in the frontal cortex and hippocampus of the rat are blocked by intracerebroventricular injection of corticotropin-releasing factor antagonist.
Lai H; Carino MA
Brain Res; 1990 Sep; 527(2):354-8. PubMed ID: 2253041
[TBL] [Abstract][Full Text] [Related]
4. Corticotrophin-releasing factor antagonist inhibits neuronal damage induced by focal cerebral ischaemia or activation of NMDA receptors in the rat brain.
Strijbos PJ; Relton JK; Rothwell NJ
Brain Res; 1994 Sep; 656(2):405-8. PubMed ID: 7820601
[TBL] [Abstract][Full Text] [Related]
5. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action.
Heinrichs SC; Pich EM; Miczek KA; Britton KT; Koob GF
Brain Res; 1992 May; 581(2):190-7. PubMed ID: 1327398
[TBL] [Abstract][Full Text] [Related]
6. Ketamine promotes hippocampal CA1 pyramidal neuron loss after a short-duration ischemic insult in rats.
Church J; Zeman S
Neurosci Lett; 1991 Feb; 123(1):65-8. PubMed ID: 2062455
[TBL] [Abstract][Full Text] [Related]
7. Brain corticotropin-releasing hormone increases arousal in stress.
Shibasaki T; Yamauchi N; Hotta M; Imaki T; Oda T; Ling N; Demura H
Brain Res; 1991 Jul; 554(1-2):352-4. PubMed ID: 1933317
[TBL] [Abstract][Full Text] [Related]
8. Autonomic and cardiovascular effects of corticotropin-releasing factor in the spontaneously hypertensive rat.
Brown MR; Hauger R; Fisher LA
Brain Res; 1988 Feb; 441(1-2):33-40. PubMed ID: 2834002
[TBL] [Abstract][Full Text] [Related]
9. Thyrotropin-releasing factor-induced adrenocorticotropin secretion is mediated by corticotropin-releasing factor.
Brown MR; Carver-Moore K; Gray TS; Rivier C
Endocrinology; 1989 Nov; 125(5):2558-62. PubMed ID: 2551657
[TBL] [Abstract][Full Text] [Related]
10. Central activation of thermogenesis by prostaglandins: dependence on CRF.
Rothwell NJ
Horm Metab Res; 1990 Dec; 22(12):616-8. PubMed ID: 2076859
[TBL] [Abstract][Full Text] [Related]
11. Central corticotropin-releasing factor suppresses natural killer cytotoxicity.
Irwin MR; Vale W; Britton KT
Brain Behav Immun; 1987 Mar; 1(1):81-7. PubMed ID: 3502536
[TBL] [Abstract][Full Text] [Related]
12. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function.
Martínez V; Rivier J; Wang L; Taché Y
J Pharmacol Exp Ther; 1997 Feb; 280(2):754-60. PubMed ID: 9023288
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of Lewis and Fischer rats to stress-induced worsening of TNB-colitis: protective role of brain CRF.
Million M; Taché Y; Anton P
Am J Physiol; 1999 Apr; 276(4):G1027-36. PubMed ID: 10198347
[TBL] [Abstract][Full Text] [Related]
14. Acidic fibroblast growth factor prevents death of hippocampal CA1 pyramidal cells following ischemia.
Sasaki K; Oomura Y; Suzuki K; Hanai K; Yagi H
Neurochem Int; 1992 Oct; 21(3):397-402. PubMed ID: 1284624
[TBL] [Abstract][Full Text] [Related]
15. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior.
Stenzel-Poore MP; Heinrichs SC; Rivest S; Koob GF; Vale WW
J Neurosci; 1994 May; 14(5 Pt 1):2579-84. PubMed ID: 8182429
[TBL] [Abstract][Full Text] [Related]
16. Behavioral effects of central administration of the novel CRF antagonist astressin in rats.
Spina MG; Basso AM; Zorrilla EP; Heyser CJ; Rivier J; Vale W; Merlo-Pich E; Koob GF
Neuropsychopharmacology; 2000 Mar; 22(3):230-9. PubMed ID: 10693150
[TBL] [Abstract][Full Text] [Related]
17. Astressin, a novel and potent CRF antagonist, is neuroprotective in the hippocampus when administered after a seizure.
Maecker H; Desai A; Dash R; Rivier J; Vale W; Sapolsky R
Brain Res; 1997 Jan; 744(1):166-70. PubMed ID: 9030428
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotection by corticotropin releasing factor during hypoxia in rat brain.
Fox MW; Anderson RE; Meyer FB
Stroke; 1993 Jul; 24(7):1072-5; discussion 1075-6. PubMed ID: 8322382
[TBL] [Abstract][Full Text] [Related]
19. Effects of nitrobenzylthioinosine on neuronal injury, adenosine levels, and adenosine receptor activity in rat forebrain ischemia.
Parkinson FE; Zhang YW; Shepel PN; Greenway SC; Peeling J; Geiger JD
J Neurochem; 2000 Aug; 75(2):795-802. PubMed ID: 10899957
[TBL] [Abstract][Full Text] [Related]
20. [Effect of the corticoliberin fragment CRF(4-6) on blood pressure and heart rate in rats].
Makarenko EIu; Andreeva LA; Borovik AS; Mart'ianov AA
Ross Fiziol Zh Im I M Sechenova; 2005 Jan; 91(1):71-9. PubMed ID: 15773582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
